Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer

NCT01992042 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Fluvastatin
DRUG: Pimonidazole

Sponsor

University Health Network, Toronto